301 related articles for article (PubMed ID: 28821412)
1. Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients.
Contoli M; Campo G; Pavasini R; Marchi I; Pauletti A; Balla C; Spanevello A; Ferrari R; Papi A
Eur J Intern Med; 2018 Jan; 47():82-86. PubMed ID: 28821412
[TBL] [Abstract][Full Text] [Related]
2. Comparative Effectiveness of Long-Acting Beta
Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA
Pharmacotherapy; 2017 Apr; 37(4):447-455. PubMed ID: 28226405
[TBL] [Abstract][Full Text] [Related]
3. Risk of pneumonia with inhaled corticosteroid versus long-acting bronchodilator regimens in chronic obstructive pulmonary disease: a new-user cohort study.
DiSantostefano RL; Sampson T; Le HV; Hinds D; Davis KJ; Bakerly ND
PLoS One; 2014; 9(5):e97149. PubMed ID: 24878543
[TBL] [Abstract][Full Text] [Related]
4. Long-Acting Bronchodilator Use in Chronic Obstructive Pulmonary Disease in Primary Care in New Zealand: A Retrospective Study of Treatment Patterns and Evolution Using the HealthStat Database.
Milea D; Yeo SH; Nam Y; Navarro Rojas AA; Shantakumar S; Beale J; Marett B; Young RP; Scott RJ; Gribben B
Int J Chron Obstruct Pulmon Dis; 2021; 16():1075-1091. PubMed ID: 33907394
[TBL] [Abstract][Full Text] [Related]
5. Risk of Cardiovascular and Cerebrovascular Events in COPD Patients Treated With Long-Acting β
Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA
Ann Pharmacother; 2017 Nov; 51(11):945-953. PubMed ID: 28677404
[TBL] [Abstract][Full Text] [Related]
6. Impact of medications on outcomes in patients with acute myocardial infarction and chronic obstructive pulmonary disease: A nationwide cohort study.
Chiang CH; Jiang YC; Hung WT; Kuo SH; Hsia K; Wang CL; Fu YJ; Lin KC; Lin SC; Cheng CC; Huang WC
J Chin Med Assoc; 2023 Feb; 86(2):183-190. PubMed ID: 36652566
[TBL] [Abstract][Full Text] [Related]
7. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
[TBL] [Abstract][Full Text] [Related]
8. Treatment patterns in patients with stable COPD in China: analysis of a prospective, 52-week, nationwide, observational cohort study (REAL).
Yang T; Cai B; Cao B; Kang J; Wen F; Chen Y; Jian W; Wang C
Ther Adv Respir Dis; 2023; 17():17534666231158283. PubMed ID: 37013442
[TBL] [Abstract][Full Text] [Related]
9. Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care.
Punekar YS; Landis SH; Wurst K; Le H
Respir Res; 2015 Nov; 16():141. PubMed ID: 26572740
[TBL] [Abstract][Full Text] [Related]
10. A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy.
Mapel D; Laliberté F; Roberts MH; Sama SR; Sundaresan D; Pilon D; Lefebvre P; Duh MS; Patel J
Int J Chron Obstruct Pulmon Dis; 2017; 12():1825-1836. PubMed ID: 28684905
[TBL] [Abstract][Full Text] [Related]
11. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L
Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
[TBL] [Abstract][Full Text] [Related]
12. Can Assessment of Disease Burden Prior to Changes in Initial COPD Maintenance Treatment Provide Insight into Remaining Unmet Needs? A Retrospective Database Study in UK Primary Care.
Landis SH; Wurst K; Le HV; Bonar K; Punekar YS
COPD; 2017 Feb; 14(1):80-85. PubMed ID: 27819513
[TBL] [Abstract][Full Text] [Related]
13. The effect of umeclidinium added to inhaled corticosteroid/long-acting β2-agonist in patients with symptomatic COPD: a randomised, double-blind, parallel-group study.
Sousa AR; Riley JH; Church A; Zhu CQ; Punekar YS; Fahy WA
NPJ Prim Care Respir Med; 2016 Jun; 26():16031. PubMed ID: 27334739
[TBL] [Abstract][Full Text] [Related]
14. The Effect on Total Mortality of Adding Inhaled Corticosteroids to Long-Acting Bronchodilators for COPD: A Real Practice Analysis in Italy.
Di Martino M; Agabiti N; Cascini S; Kirchmayer U; Bauleo L; Fusco D; Belleudi V; Pinnarelli L; Voci C; Patorno E; Pistelli R; Davoli M;
COPD; 2016 Jun; 13(3):293-302. PubMed ID: 26514912
[TBL] [Abstract][Full Text] [Related]
15. Long-acting Muscarinic Antagonist Versus Inhaled Corticosteroid when Added to Long-acting β-agonist for COPD: A Meta-analysis.
Oba Y; Chandran AV; Devasahayam JV
COPD; 2016 Dec; 13(6):677-685. PubMed ID: 27148815
[TBL] [Abstract][Full Text] [Related]
16. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
[TBL] [Abstract][Full Text] [Related]
17. Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform.
Schultze A; Walker AJ; MacKenna B; Morton CE; Bhaskaran K; Brown JP; Rentsch CT; Williamson E; Drysdale H; Croker R; Bacon S; Hulme W; Bates C; Curtis HJ; Mehrkar A; Evans D; Inglesby P; Cockburn J; McDonald HI; Tomlinson L; Mathur R; Wing K; Wong AYS; Forbes H; Parry J; Hester F; Harper S; Evans SJW; Quint J; Smeeth L; Douglas IJ; Goldacre B;
Lancet Respir Med; 2020 Nov; 8(11):1106-1120. PubMed ID: 32979987
[TBL] [Abstract][Full Text] [Related]
18. Triple therapy
Cazzola M; Rogliani P; Calzetta L; Matera MG
Eur Respir J; 2018 Dec; 52(6):. PubMed ID: 30309975
[TBL] [Abstract][Full Text] [Related]
19. GOLD 2017 treatment pathways in 'real life': An analysis of the DACCORD observational study.
Worth H; Buhl R; Criée CP; Kardos P; Lossi NS; Vogelmeier CF
Respir Med; 2017 Oct; 131():77-84. PubMed ID: 28947047
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis.
Hurst JR; Dilleen M; Morris K; Hills S; Emir B; Jones R
Int J Chron Obstruct Pulmon Dis; 2018; 13():781-792. PubMed ID: 29551894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]